Mapping technological capabilities into product markets and competitive advantage: the case of cholesterol drugs | Zendy

Afuah Allan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Mapping technological capabilities into product markets and competitive advantage: the case of cholesterol drugs

Author(s) -

Afuah Allan

Publication year - 2002

Publication title -

strategic management journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 11.035

H-Index - 286

eISSN - 1097-0266

pISSN - 0143-2095

DOI - 10.1002/smj.221

Subject(s) - competitive advantage , software deployment , industrial organization , business , product (mathematics) , value (mathematics) , empirical evidence , customer value , marketing , computer science , economics , microeconomics , profit (economics) , philosophy , geometry , mathematics , epistemology , machine learning , operating system

While a lot of attention has been paid to those characteristics of capabilities that give firms a competitive advantage, a lot less attention has been given to supporting empirical evidence and to the deployment of these capabilities. This paper presents a model for mapping firm capabilities into customer value and competitive advantage in different markets. With empirical evidence from cholesterol drugs, I illustrate how the model can be used to estimate customer value and competitive advantage from technological capabilities. Copyright © 2002 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research